ARCHIVES

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

House Figures for NCI, NIH Will Be Known This Week; Senate Probably Will Wait Until After Recess

July 31, 1987

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011